In general, KRAS mutations are linked to poorer prognosis, probably also influenced by tumor subtypes and co-occurring mutations.10 An important consideration regarding oncogenic KRAS mutations is the role of a co-existing wild-type (WT) allele. Here, KRAS is linked to neoplasm.